First-line therapy for ovarian cancer with carboplatin followed by paclitaxel-gemcitabine (SCOTROC5): a feasibility study and comparative analysis of the SCOTROC series

Scottish Gynecological Cancers Trials Group, Roshan Agarwal, Charles Gourley, Timothy J Perren, Nicholas Reed, David E Parkin, Karen Carty, Gordon J S Rustin, Hani Gabra, Jim Paul, Martin E Gore, Stanley B Kaye

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'First-line therapy for ovarian cancer with carboplatin followed by paclitaxel-gemcitabine (SCOTROC5): a feasibility study and comparative analysis of the SCOTROC series'. Together they form a unique fingerprint.

Medicine & Life Sciences